Gossamer Bio is trading 16.34% down at $0.15, based on the provided live-market price; no clear company-specific catalyst has been identified for September 9, 2026.
- Scheduled to present at the Cantor Global Healthcare Conference at 10:55 a.m. ET.
- The event was announced September 4 and does not explain the decline; broader indices are only modestly lower.